GE HealthCare Expands On-Device Triage Capabilities of Critical Care Suite with FDA Clearance of Algorithm for Pneumothorax Detection, Notification, Triage and Diagnosis
29 November 2023 - 1:46AM
Business Wire
- As part of the latest Critical Care Suite 2.1 offering, new
on-device AI helps detect and localize pneumothorax (PTX) –
providing immediate notification and overlay for the presence or
absence of PTX.
- Results from various clinical studies showed significant user
benefits - including a 57% reduction in reporting times for
clinical actionable PTXs;1 a 17.7% increase in clinician
detection of small PTXs;2 and a 100% partial localization
accuracy for detected large PTXs.3
Today GE HealthCare (Nasdaq: GEHC) announced an industry-first
US FDA 510K clearance of Critical Care Suite 2.1 featuring a
Pneumothorax (PTX) algorithm for the detection,
notification, triage and diagnosis of PTX. The updated PTX
algorithm expands Critical Care Suite’s on-device triage
capabilities by providing immediate notification of the presence or
absence of pneumothorax, as well as an overlay display both
on-device and in PACS to assist with PTX localization.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20231128224829/en/
On-device, CCS2.1 output from GE
HealthCare's AMX Navigate mobile X-ray system showing PTX overlay
and confidence level. (Photo: GE HealthCare)
X-ray is the oldest form of imaging and a valuable tool on the
frontlines of patient care, accounting for over 60 percent of all
imaging exams.4 Today, as technologists, radiologists, and
physicians remain under tremendous pressure to manage an
ever-increasing number of cases, every minute counts when dealing
with high-risk procedures and critical conditions like PTX. With
the high number of chest X-rays ordered as “STAT,” or immediate
priority, the triaging of true STAT orders remains a challenge.5
6
As the entry point to diagnostic imaging in the emergency room,
inpatient bedside imaging and the intensive care unit (ICU), GE
HealthCare continues to reinvent mobile X-ray to be one of the most
intuitive and technologically powerful imaging tools available to
help clinicians respond fast without compromising diagnostic
precision.
With this latest update, Critical Care Suite 2.1 provides
immediate on-device detection and triage notifications for the
presence or absence of pneumothorax (PTX). When a PTX is detected,
an overlay is displayed in the area where the PTX was located both
on-device as well as in PACS to assist with PTX localization, as
well as improve speed and accuracy of PTX diagnosis. By hosting
Critical Care Suite on-device, critical insights are available at
the point of care and across the entire clinical care team.
Early users of this technology see the benefit of bedside access
to critical clinical information:
“The ultimate journey for an AI tool from bench to bedside is
when you involve the entire clinical team including bedside
Physicians, Nurse Practitioners and Radiologists,” says Dr Amit
Gupta - Division Chief of Cardiothoracic Imaging, University
Hospitals of Cleveland. “GE HealthCare’s innovation with Critical
Care Suite to have alerts on mobile systems is helping clinicians
make decisions with confidence in these critical moments.”
The algorithm operates with a high degree of accuracy –
partially localizing 100% of all detected large PTXs and 96% of all
detected small PTXs, while limiting false alerts (94%
specificity).7
Results from various clinical studies also showed significant
user benefits when using this technology including a 57% reduction
in reporting times for clinical actionable PTXs8 and a 17.7%
increase in clinician detection of small PTXs.9
“Artificial intelligence applications in healthcare continue to
prove their value in clinical practice and on the frontlines of
patient care,” shares Jyoti Gupta PhD, President & CEO of
Women’s Health and X-ray for GE HealthCare. “The adoption of these
digital solutions helps unlock efficiencies across the entire
clinical workflow and empowers radiologists and their teams in
making critical decisions with confidence in time-sensitive
situations. We are excited by the paradigm shift this kind of
innovation can bring in the delivery of timely and efficient
patient care enabling enhanced clinical outcomes when it matters
most.”
GE HealthCare’s Critical Care Suite was co-developed with UCSF's
Center for Digital Health Innovation (CDHI) and the company’s AMX
platform is the first mobile X-ray system in the world to offer
this on-device embedded artificial intelligence for triage. In
addition to the on-device AI notifications, the AI output is also
sent directly to PACS via a secondary capture DICOM image to enable
rapid review by the radiologist - enabling seamless integration at
the point of care without the need for additional IT
infrastructure. The robust AI algorithm is trained on a large,
global, diverse data set that includes more than 30,000 images from
multiple countries and institutions.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology,
pharmaceutical diagnostics, and digital solutions innovator,
dedicated to providing integrated solutions, services, and data
analytics to make hospitals more efficient, clinicians more
effective, therapies more precise, and patients healthier and
happier. Serving patients and providers for more than 100 years, GE
HealthCare is advancing personalized, connected, and compassionate
care, while simplifying the patient’s journey across the care
pathway. Together our Imaging, Ultrasound, Patient Care Solutions,
and Pharmaceutical Diagnostics businesses help improve patient care
from diagnosis, to therapy, to monitoring. We are an $18.3 billion
business with 50,000 employees working to create a world where
healthcare has no limits.
Follow us on Facebook, LinkedIn, Twitter, Instagram, and
Insights for the latest news, or visit our website
https://www.gehealthcare.com/ for more information.
1 https://archive.rsna.org/2022/133200000.html 2 GE HealthCare
510K K223491. 3 GE HealthCare 510K K223491. 4 World Health
Organization Report -Communicating Radiation Risks in Pediatric
Imaging. 5 “A Pilot Study.” Current problems in diagnostic
radiology (2017). 6 Lorenz, Jonathan, and Matthew Blum.
“Complications of percutaneous chest biopsy.” Seminars in
interventional radiology. Vol. 23. No. 2. Thieme Medical
Publishers, 2006. 7 GE HealthCare 510K K223491. 8
https://archive.rsna.org/2022/133200000.html 9 GE HealthCare 510K
K223491.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231128224829/en/
Media Contact: Emily Dalton Niles Emily.niles@ge.com
GE HealthCare Technologies (NASDAQ:GEHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
GE HealthCare Technologies (NASDAQ:GEHC)
Historical Stock Chart
From Jul 2023 to Jul 2024